scholarly journals What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?

Author(s):  
Remco de Bree ◽  
Bart de Keizer ◽  
Francisco J. Civantos ◽  
Robert P. Takes ◽  
Juan P. Rodrigo ◽  
...  

AbstractApproximately 70–80% of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic staging method to intelligently identify patients who would benefit from formal selective lymphadenectomy or neck irradiation. While not yet universally accepted, SLNB is now incorporated in many national guidelines. SLNB offers a less invasive alternative to elective neck dissection (END), and has some advantages and disadvantages. SLNB can assess the individual drainage pattern and, with step serial sectioning and immunohistochemistry (IHC), can enable the accurate detection of micrometastases and isolated tumor cells (ITCs). Staging of the neck is improved relative to END with routine histopathological examination. The improvements in staging are particularly notable for the contralateral neck and the pretreated neck. However, for floor of mouth (FOM) tumors, occult metastases are frequently missed by SLNB due to the proximity of activity from the primary site to the lymphatics (the shine through phenomenon). For FOM cancers, it is advised to perform either elective neck dissection or superselective neck dissection of the preglandular triangle of level I. New tracers and techniques under development may improve the diagnostic accuracy of SLNB for early-stage OSCC, particularly for FOM tumors. Treatment of the neck (either neck dissection or radiotherapy), although limited to levels I–IV, remains mandatory for any positive category of metastasis (macrometastasis, micrometastasis, or ITCs). Recently, the updated EANM practical guidelines for SLN localization in OSCC and the surgical consensus guidelines on SLNB in patients with OSCC were published. In this review, the current evidence and results of SLNB in early OSCC are presented.

2018 ◽  
Vol 129 (1) ◽  
pp. 162-169 ◽  
Author(s):  
John D. Cramer ◽  
Shaum Sridharan ◽  
Robert L. Ferris ◽  
Umamaheswar Duvvuri ◽  
Sandeep Samant

2018 ◽  
Vol 47 (1) ◽  
Author(s):  
Marco Roberto Seferin ◽  
Fábio Roberto Pinto ◽  
Chin Shien Lin ◽  
Ana Kober Nogueira Leite ◽  
Paulo Vitor Sola Gimenes ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 1783 ◽  
Author(s):  
Inne J. den Toom ◽  
Koos Boeve ◽  
Daphne Lobeek ◽  
Elisabeth Bloemena ◽  
Maarten L. Donswijk ◽  
...  

Background: Sentinel lymph node biopsy (SLNB) has been introduced as a diagnostic staging modality for detection of occult metastases in patients with early stage oral cancer. Comparisons regarding accuracy to the routinely used elective neck dissection (END) are lacking in literature. Methods: A retrospective, multicenter cohort study included 390 patients staged by END and 488 by SLNB. Results: The overall sensitivity (84% vs. 81%, p = 0.612) and negative predictive value (NPV) (93%, p = 1.000) were comparable between END and SLNB patients. The END cohort contained more pT2 tumours (51%) compared to the SLNB cohort (23%) (p < 0.001). No differences were found for sensitivity and NPV between SLNB and END divided by pT stage. In floor-of-mouth (FOM) tumours, SLNB had a lower sensitivity (63% vs. 92%, p = 0.006) and NPV (90% vs. 97%, p = 0.057) compared to END. Higher disease-specific survival (DSS) rates were found for pT1 SLNB patients compared to pT1 END patients (96% vs. 90%, p = 0.048). Conclusion: In the absence of randomized clinical trials, this study provides the highest available evidence that, in oral cancer, SLNB is as accurate as END in detecting occult lymph node metastases, except for floor-of-mouth tumours.


Sign in / Sign up

Export Citation Format

Share Document